Argitalpenak (74) LUIS MENENDEZ ANTOLIN argitalpenak

2024

  1. Hyperalgesic Effect Evoked by il-16 and its Participation in Inflammatory Hypernociception in Mice

    Journal of Neuroimmune Pharmacology, Vol. 19, Núm. 1

2023

  1. Experiences and reflections about behavioral pain assays in laboratory animals

    Journal of Neuroscience Methods, Vol. 386

2022

  1. Involvement of CD4+ and CD8+ T-lymphocytes in the modulation of nociceptive processing evoked by CCL4 in mice

    Life Sciences, Vol. 291

2021

  1. Kappa-opioid receptor-mediated thermal analgesia evoked by the intrathecal administration of the chemokine CCL1 in mice

    Fundamental and Clinical Pharmacology, Vol. 35, Núm. 6, pp. 1109-1118

  2. Social aspects of drugs in the Medical Degree of the University of Oviedo

    Educacion Medica, Vol. 22, pp. 352-357

2020

  1. A low pKa ligand inhibits cancer-associated pain in mice by activating peripheral mu-opioid receptors

    Scientific Reports, Vol. 10, Núm. 1

  2. Dual dose-related effects evoked by CCL4 on thermal nociception after gene delivery or exogenous administration in mice

    Biochemical Pharmacology, Vol. 175

2019

  1. The Chemokine CCL4 (MIP-1β) Evokes Antinociceptive Effects in Mice: a Role for CD4 + Lymphocytes and Met-Enkephalin

    Molecular Neurobiology, Vol. 56, Núm. 3, pp. 1578-1595

  2. The Systemic Administration of the Chemokine CCL1 Evokes Thermal Analgesia in Mice Through the Activation of the Endocannabinoid System

    Cellular and Molecular Neurobiology, Vol. 39, Núm. 8, pp. 1115-1124

2017

  1. Hyperalgesic and hypoalgesic mechanisms evoked by the acute administration of CCL5 in mice

    Brain, Behavior, and Immunity, Vol. 62, pp. 151-161

  2. Synergistic combinations of the dual enkephalinase inhibitor PL265 given orally with various analgesic compounds acting on different targets, in a murine model of cancer-induced bone pain

    Scandinavian Journal of Pain, Vol. 14, pp. 25-38

2016

  1. Analgesic effects evoked by a CCR2 antagonist or an anti-CCL2 antibody in inflamed mice

    Fundamental and Clinical Pharmacology, Vol. 30, Núm. 3, pp. 235-247

  2. Involvement of CC Chemokine Receptor 1 and CCL3 in Acute and Chronic Inflammatory Pain in Mice

    Basic & clinical pharmacology & toxicology, Vol. 119, Núm. 1, pp. 32-40

2015

  1. Hypernociceptive responses following the intratibial inoculation of RM1Prostate cancer cells in mice

    Prostate, Vol. 75, Núm. 1, pp. 70-83

  2. Los analgésicos secundarios (2): antiepilépticos

    Tratamiento del dolor: teoría y práctica (Permanyer), pp. 89-92

2014

  1. Involvement of spinal chemokine ccl2 in the hyperalgesia evoked by bone cancer in mice: A role for astroglia and microglia

    Cellular and Molecular Neurobiology, Vol. 34, Núm. 1, pp. 143-156

  2. The chemokine CCL5 induces CCR1-mediated hyperalgesia in mice inoculated with NCTC 2472 tumoral cells

    Neuroscience, Vol. 259, pp. 113-125

2013

  1. Fármacos que actúan modulando la actividad enzimática

    Fundamentos de farmacología básica y clínica (Editorial Médica Panamericana), pp. 191-204

  2. Spinal CCL2 and microglial activation are involved in paclitaxel-evoked cold hyperalgesia

    Brain Research Bulletin, Vol. 95, pp. 21-27

2012

  1. An inhibitor of neuronal exocytosis (DD04107) displays long-lasting in vivo activity against chronic inflammatory and neuropathic pain

    Journal of Pharmacology and Experimental Therapeutics, Vol. 341, Núm. 3, pp. 634-645